Valuation Abbott Laboratories

Stocks

Real-time Estimate Cboe BZX Other stock markets 22:54:35 29/07/2026 HKT			5-day change	1st Jan Change
109.14 ^USD	+1.75%		+8.79%	-12.67%

07-28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
07-28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	241,365	191,427	191,088	196,184	217,859	186,844	-	-
Change	-	-20.69%	-0.18%	2.67%	11.05%	-14.24%	-	-
Enterprise Value (EV) ¹	249,166	198,318	198,871	202,693	222,266	211,010	208,260	204,460
Change	-	-20.41%	0.28%	1.92%	9.66%	-5.06%	-1.3%	-1.83%
P/E	35.7x	28.1x	33.8x	14.8x	33.7x	30.7x	23.7x	21.3x
PBR	6.93x	5.2x	4.94x	4.11x	4.18x	3.86x	3.69x	3.48x
PEG	-	-36.9x	-2x	0x	-0.7x	-5.02x	0.8x	1.9x
Capitalization / Revenue	5.6x	4.39x	4.76x	4.68x	4.91x	3.71x	3.42x	3.2x
EV / Revenue	5.78x	4.54x	4.96x	4.83x	5.01x	4.19x	3.81x	3.5x
EV / EBITDA	19.4x	15.9x	19.5x	19.1x	18.9x	16.3x	14.4x	12.9x
EV / EBIT	22x	17.7x	22.3x	21.8x	21.6x	18x	16x	14.3x
EV / FCF	28.8x	25.4x	39.3x	31.9x	30.1x	26.6x	22.3x	20x
FCF Yield	3.47%	3.94%	2.54%	3.13%	3.33%	3.76%	4.49%	4.99%
Dividend per Share ²	1.82	1.92	2.08	2.24	2.4	2.577	2.739	2.854
Rate of return	1.29%	1.75%	1.89%	1.98%	1.92%	2.4%	2.55%	2.66%
EPS ²	3.94	3.91	3.26	7.64	3.72	3.492	4.522	5.038
Distribution rate	46.2%	49.1%	63.8%	29.3%	64.5%	73.8%	60.6%	56.7%
Net sales ¹	43,075	43,653	40,109	41,950	44,328	50,304	54,649	58,413
EBITDA ¹	12,815	12,485	10,188	10,635	11,735	12,951	14,445	15,797
EBIT ¹	11,324	11,231	8,911	9,295	10,301	11,718	13,019	14,321
Net income ¹	7,071	6,933	5,723	13,402	6,524	6,255	7,923	8,786
Net Debt ¹	7,801	6,891	7,783	6,509	4,407	24,166	21,416	17,615
Reference price ²	140.74	109.79	110.07	113.11	125.29	107.27	107.27	107.27
Nbr of stocks (in thousands)	1,714,968	1,743,574	1,736,059	1,734,455	1,738,834	1,741,813	-	-
Announcement Date	26/1/22	25/1/23	24/1/24	22/1/25	22/1/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ABBOTT LABORATORIES	30.71x	4.19x	16.29x	2.4%	187B
MEDTRONIC PLC	19.69x	3.43x	12.07x	3.42%	111B
CENCORA, INC.	17.78x	0.2x	12.52x	0.74%	62.18B
HOYA CORPORATION	29.88x	7.24x	18.9x	1.34%	48.4B
BECTON, DICKINSON AND COMPANY	36.22x	3.23x	11.01x	2.36%	45.83B
MEDLINE INC.	38.84x	1.41x	12.39x	0.25%	34.26B
DEXCOM, INC.	30.28x	5.43x	17.3x	-.--%	28.88B
WEST PHARMACEUTICAL SERVICES, INC.	39.3x	6.88x	24.65x	0.27%	23.72B
STERIS PLC	25.36x	3.69x	13.29x	1.14%	22.45B
TERUMO CORPORATION	20.2x	2.79x	10.86x	1.56%	20.63B
Average	28.83x	3.85x	14.93x	1.35%	58.44B
Weighted average by Cap.	27.83x	3.74x	14.74x	1.92%